For example, lung epithelial- or myeloid-specific PDLIM2 deletion or global PDLIM2 deletion in mice promotes lung cancer development, chemoresistance, and/or causes complete resistance to immune checkpoint inhibitors (ICIs) (20–22). Here, PDLIM2 is linked to lung carcinoma.